Please use this identifier to cite or link to this item:
|Title:||Gene expression signatures: A new approach to understanding the pathophysiology of chronic rhinosinusitis||Authors:||Li, C.
|Keywords:||Chronic rhinosinusitis (CRS)
Gene expression signatures
Host defense mechanisms
Regulatory T cells (T-reg)
|Issue Date:||Apr-2013||Citation:||Li, C., Shi, L., Yan, Y., Gordon, B.R., Gordon, W.M., Wang, D.-Y. (2013-04). Gene expression signatures: A new approach to understanding the pathophysiology of chronic rhinosinusitis. Current Allergy and Asthma Reports 13 (2) : 209-217. ScholarBank@NUS Repository. https://doi.org/10.1007/s11882-012-0328-6||Abstract:||Chronic rhinosinusitis (CRS) is a complex inflammatory disease with variable disease manifestation. Though external risk factors are associated with development and/or persistence of CRS, the host mucosal response is also important, as nasal epithelium acts as a physical and immune barrier. Under inflammatory stress, the nasal epithelium can undergo injury, followed by a rapid remodeling response ranging from epithelial hyperplasia, to goblet-cell metaplasia, to denudation, loss of cilia, fibrosis, and basement membrane thickening. Identification of gene expression signatures and molecular pathways in CRS pathogenesis have now begun to contribute significantly to a better understanding of the genetic and molecular alterations underlying CRS development and progression. Genetic studies are especially illuminating when multiple gene variants synergize within a permissive environmental context, and are expected to guide development of more effective therapeutic targets for CRS treatment. © 2012 Springer Science+Business Media New York.||Source Title:||Current Allergy and Asthma Reports||URI:||http://scholarbank.nus.edu.sg/handle/10635/109360||ISSN:||15297322||DOI:||10.1007/s11882-012-0328-6|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.